Search clinical trials for: Pioglitazone (drug) and/or candesartan (drug)
Total 254162 results
-
Pharmtechnology LLCAltasciences Company, Inc.Completed
-
TakedaCompletedType 2 Diabetes Mellitus and MicroalbuminuriaJapan
-
HK inno.N CorporationCompleted
-
Qianfoshan HospitalCompleted
-
Dana-Farber Cancer InstituteCompletedAdvanced Solid Tumor | Metastatic Solid TumorUnited States
-
TakedaCompleted
-
Boryung Pharmaceutical Co., LtdCompleted
-
St. Louis UniversityWithdrawnInsulin Resistance | Prostate CancerUnited States
-
University of MichiganNational Heart, Lung, and Blood Institute (NHLBI)CompletedRheumatoid ArthritisUnited States
-
Mitsubishi Tanabe Pharma CorporationCompletedType 2 Diabetes MellitusJapan
-
Skane University HospitalMedical Research Council; Skane County Council Research & Development FoundationCompletedType 2 Diabetes | Secondary Drug FailureSweden
-
Slovak Academy of SciencesUnknown
-
AstraZenecaTakedaCompletedObservational Usage and Efficacy Study of Candesartan in Heart Failure Treatment in France (SISTOLA)Heart Failure | Cohort StudyFrance
-
Mitsubishi Tanabe Pharma CorporationCompletedChronic Kidney Disease | HyperphosphatemiaUnited Kingdom
-
AstraZenecaCompletedPrimary HypertensionRomania
-
Boehringer IngelheimCompletedDiabetes Mellitus, Type 2United States, Argentina, Austria, Belgium, Canada, China, Croatia, Czech Republic, Finland, Germany, Greece, Hungary, India, Israel, Italy, Japan, Korea, Republic of, Malaysia, Mexico, Netherlands, New Zealand, Philippines, Poland, R... and more
-
Mylan Pharmaceuticals IncCompleted
-
TakedaCompleted
-
Torrent Pharmaceuticals LimitedCompleted
-
BayerCompletedHypertension, EssentialGermany
-
Kinarus AGSuspended
-
Mayo ClinicNational Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)CompletedDiabetes Mellitus, Type 2United States
-
University of HelsinkiAstraZenecaUnknownAortic Valve StenosisFinland
-
EMSNot yet recruiting
-
Kaiser PermanenteUniversity of California, DavisWithdrawnHepatitis CUnited States
-
Emory UniversityMerck Sharp & Dohme LLCTerminated
-
National Center for Research Resources (NCRR)CompletedDiabetes Mellitus | Insulin ResistanceUnited States
-
Brigham and Women's HospitalNational Heart, Lung, and Blood Institute (NHLBI)CompletedInsulin Resistance | Intermittent Claudication | Arterial Occlusive DiseaseUnited States
-
HK inno.N CorporationUnknownEssential HypertensionKorea, Republic of
-
Chong Kun Dang PharmaceuticalCompleted
-
AstraZenecaScentryphar Clinical Research; Cori Analyticals; Clínica São Lucas, Hospital... and other collaboratorsCompleted
-
National Institute on Aging (NIA)Takeda Pharmaceuticals North America, Inc.Completed
-
Mylan Pharmaceuticals IncCompleted
-
Stanford UniversityCompletedObesity | Metabolic Syndrome | Impaired Glucose ToleranceUnited States
-
BayerCompletedHypertension, EssentialSpain, Argentina, United States, Canada, Korea, Republic of, Italy, Russian Federation, South Africa, Ukraine, Belgium, Brazil, Lithuania, United Kingdom
-
AstraZenecaCompletedStage II HypertensionKorea, Republic of
-
Nanjing First Hospital, Nanjing Medical UniversityNot yet recruitingInsulin Resistance | Type2diabetes
-
AstraZenecaCompletedHypertensionRussian Federation, Latvia, Romania, Slovakia, Belgium, Malta
-
TakedaCompleted
-
Montreal Heart InstituteAstraZenecaCompleted
-
Daiichi Sankyo Co., Ltd.Completed
-
Novo Nordisk A/STerminatedDiabetes Mellitus, Type 2 | DiabetesUnited States
-
The Netherlands Cancer InstituteRoche Pharma AG; AstraZenecaCompletedBreast CancerNetherlands
-
Parke-DavisCompletedDiabetes Mellitus | AtherosclerosisUnited States
-
HK inno.N CorporationCompleted
-
TakedaCompleted
-
Shin Poong Pharmaceutical Co. Ltd.CompletedEssential HypertensionKorea, Republic of
-
Oregon Health and Science UniversityCompleted